{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:49:51Z","timestamp":1783759791167,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jacc.2017.12.052","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T17:30:53Z","timestamp":1519666253000},"page":"994-1004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Cardiovascular Risks of Probenecid\u00a0Versus Allopurinol in Older\u00a0Patients With\u00a0Gout"],"prefix":"10.1016","volume":"71","author":[{"given":"Seoyoung C.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuhina","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi J.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaryAnn","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.12.052_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","article-title":"Epidemiology of gout","volume":"40","author":"Roddy","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jacc.2017.12.052_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Clinical practice. Gout","volume":"364","author":"Neogi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.12.052_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2017.12.052_bib4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jacc.2017.12.052_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0773.1965.tb00358.x","article-title":"The tubular site of urate transport in the rabbit kidney, and the effect of probenecid on urate secretion","volume":"23","author":"Moller","year":"1965","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.jacc.2017.12.052_bib6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2009.122770","article-title":"Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study","volume":"69","author":"De Vera","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2017.12.052_bib7","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","article-title":"Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies","volume":"52","author":"Seminog","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jacc.2017.12.052_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2017.12.052_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.12.052_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07435800.2011.566235","article-title":"Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia","volume":"37","author":"Melendez-Ramirez","year":"2012","journal-title":"Endocr Res"},{"key":"10.1016\/j.jacc.2017.12.052_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000235731","article-title":"Combination of captopril and allopurinol retards fructose-induced metabolic syndrome","volume":"30","author":"Roncal","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jacc.2017.12.052_bib12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) study","volume":"131","author":"Givertz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.12.052_bib13","doi-asserted-by":"crossref","first-page":"653.e7","DOI":"10.1016\/j.amjmed.2015.01.013","article-title":"Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study","volume":"128","author":"Kim","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2017.12.052_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.amjmed.2015.11.003","article-title":"Effect of allopurinol on cardiovascular outcomes in hyperuricemic patients: a cohort study","volume":"129","author":"Larsen","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2017.12.052_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12872-017-0513-6","article-title":"Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes","volume":"17","author":"Singh","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2017.12.052_bib16","first-page":"80","article-title":"Renal transport of urate in humans","volume":"14","author":"Roch-Ramel","year":"1999","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.jacc.2017.12.052_bib17","doi-asserted-by":"crossref","first-page":"C761","DOI":"10.1152\/ajpcell.00227.2008","article-title":"Probenecid, a gout remedy, inhibits pannexin 1 channels","volume":"295","author":"Silverman","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jacc.2017.12.052_bib18","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.108.772491","article-title":"Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist","volume":"117","author":"Fearon","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.12.052_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1074248412469299","article-title":"Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model","volume":"18","author":"Koch","year":"2013","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacc.2017.12.052_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2007.08.035","article-title":"Transient receptor potential V2 expressed in sensory neurons is activated by probenecid","volume":"425","author":"Bang","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jacc.2017.12.052_bib21","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.cardfail.2015.06.163","article-title":"Probenecid improves cardiac function in patients with heart failure. Interim analysis of the Re-Prosper HF trial","volume":"21 Suppl","author":"Gilbert","year":"2015","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2017.12.052_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.trsl.2013.02.003","article-title":"Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease","volume":"161","author":"Robbins","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.jacc.2017.12.052_bib23","doi-asserted-by":"crossref","first-page":"H574","DOI":"10.1152\/ajpheart.00854.2013","article-title":"Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance","volume":"306","author":"Rubinstein","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2017.12.052_bib24","series-title":"Pharmacoepidemiology","first-page":"209","article-title":"US Government claims databases","author":"Hennessy","year":"2012"},{"key":"10.1016\/j.jacc.2017.12.052_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pds.2312","article-title":"A\u00a0systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data","volume":"21 Suppl 1","author":"Andrade","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2017.12.052_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.12.052_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCOUTCOMES.113.000743","article-title":"Validity of claims-based stroke algorithms in contemporary Medicare data: Reasons for Geographic and Racial Differences in Stroke (REGARDS) study linked with Medicare claims","volume":"7","author":"Kumamaru","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2017.12.052_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A\u00a0combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2017.12.052_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2017.12.052_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pds.3263","article-title":"One-to-many propensity score matching in cohort studies","volume":"21 Suppl 2","author":"Rassen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2017.12.052_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.jacc.2017.12.052_bib32","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.6058","article-title":"Metrics for covariate balance in cohort studies of causal effects","volume":"33","author":"Franklin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2017.12.052_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/epirev\/mxg002","article-title":"Matched cohort methods for injury research","volume":"25","author":"Cummings","year":"2003","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jacc.2017.12.052_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(81)90116-1","article-title":"Vasectomy and non-fatal myocardial infarction","volume":"1","author":"Walker","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.12.052_bib35","series-title":"Survival Analysis: A Self-Learning Text","first-page":"161","article-title":"Evaluating the proportional hazards assumption","author":"Kleinbaum","year":"2012"},{"key":"10.1016\/j.jacc.2017.12.052_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.12.052_bib37","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1beta inhibition with canakinumab on hemoglobin a1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718300263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718300263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:15:22Z","timestamp":1760015722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718300263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0735109718300263"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.12.052","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risks of Probenecid\u00a0Versus Allopurinol in Older\u00a0Patients With\u00a0Gout","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.12.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}